Dillico

DILLICO is a French deep tech company with the mission to revolutionize the way mRNA pharmaceuticals are developed and manufactured by radically simplifying the mRNA manufacturing process. DILLICO is developing, industrializing and deploying the first end-to-end mRNA manufacturing platform enabling for the GMP (Good Manufacturing Practices) manufacturing of mRNA therapies at any scale with a very compact skid. A whole new concept for “mRNAfacturing” based on unprecedented agility and scalability will emerge from this development to become a mainstream solution to the attention of mRNA players in the pharma and biotech industry (i.e., Big Pharma strongly engaged in mRNA, mRNA biotech specialists, CDMOs, Biotech companies willing to develop an mRNA platform).